Aldeyra Therapeutics

3 followers

‌

Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.

Industries

Pharmaceutical

Headquarters

Lexington, United States

Employees

11-50

Links

Org chart

Todd C. Brady

CEO & President

Todd C. Brady

Collapse

Christopher Pearson

Vice President, Commercial Development and Strategy

David J. Clark

Chief Medical Officer

David Noskowitz

Vice President, Regulatory Affairs

Lise L. Kjems

Vice President, Clinical Development

Stephen G. Machatha

Senior Vice President, Technical Operations

Annalisa Webb

Assistant Controller

Teams

Leadership Team

6 members

Clinical and Commercial Development

5 members

Quality and Regulatory

3 members

Finance

2 members

Offices

Similar companies

Charlie Health

6 followers

HistoSonics

3 followers

Madrigal Pharmaceuticals

2 followers

Astria Therapeutics

1 follower

Bristol-Myers Squibb

207 followers

Viatris

38 followers

Syneos Health

23 followers

Catalent

20 followers

Organon

17 followers

Parexel

9 followers

Agios Pharmaceuticals

5 followers

Explore companies